Alnylam Pharmaceuticals, Inc. - ALNY

About Gravity Analytica
Recent News
- 05.13.2026 - 2026 Alnylam 2030 strategy announced
- 05.13.2026 - 2026 Alnylam 2030 strategy announced
- 04.20.2026 - Silence Disease Ireland
Recent Filings
- 05.06.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 04.30.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 04.30.2026 - EX-99.1 EX-99.1
- 04.30.2026 - 8-K Current report
- 04.29.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
- 04.07.2026 - 3 Initial statement of beneficial ownership of securities
- 04.07.2026 - 4 Statement of changes in beneficial ownership of securities
- 04.06.2026 - DEF 14A Other definitive proxy statements
- 04.06.2026 - 144 Report of proposed sale of securities
- 04.06.2026 - ARS Annual Report to Security Holders